A phase ii study of capecitabine (c), oxaliplatin (o) and bevacizumab (b) using a 2-weekly schedule in previously untreated patients (pts) with advanced, unresectable colorectal cancer (crc) - cancer trials new zealand study 05-6

Files in this item

Find Full text

This item appears in the following Collection(s)

Share

Search ResearchSpace


Browse

Statistics